MedTrace Logo

VASCULUX-examination of the Pulmonary VASCUlar Barrier in Patients During LUng Transplantation

NCT02225249 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2014-08-26

No results posted yet for this study

Summary

Lung transplantation is a well established method for surgical therapy for patients with end stage pulmonary disease.

The investigators seek to determine to which extent the pulmonary vascular barrier gets harmed during lung transplantation and whether pulmonary edema after reperfusion can be monitored with measurement of extravascular lung water index (ELWI).

Additionally the investigaors are going to evaluate the correlation between ELWI and shedding of the endothelial glycocalyx.

The study is designed as a prospective observational cohort study.

Conditions

  • End Stage Chronic Obstructive Airways Disease

Sponsors & Collaborators

  • Ludwig-Maximilians - University of Munich

    lead OTHER

Principal Investigators

  • Dirk Bruegger, MD · Medical Faculty of Ludwig-Maximilians-University Munich

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2016-10-31
Completion
2017-07-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02225249 on ClinicalTrials.gov